Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial
Diabetes, Obesity and Metabolism, 01/19/2011
Clinical Article
Garg SK et al. – During this short–term pilot study, colesevelam treatment effectively lowered lipoprotein cholesterol (LDL–C) in patients with type 1 diabetes.



